Announcement of a Limited Competition for the Continuation of the Cooperative Agreement on the Interaction of HIV Infection and Alcohol Abuse on Central Nervous System Morbidity (U01)

The summary for the Announcement of a Limited Competition for the Continuation of the Cooperative Agreement on the Interaction of HIV Infection and Alcohol Abuse on Central Nervous System Morbidity (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Announcement of a Limited Competition for the Continuation of the Cooperative Agreement on the Interaction of HIV Infection and Alcohol Abuse on Central Nervous System Morbidity (U01): The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites a limited competing renewal of a cooperative agreement application to evaluate the cumulative and progressive effects on the brain of combined HIV infection and alcohol abuse using advanced in vivo magnetic resonance imaging methods. The investigator will work collaboratively under the cooperative agreement with NIAAA over a five-year period to conduct investigations of the separate and interactive effects of chronic alcohol use and HIV infection on neurocognitive function and brain structural and functional integrity. The long-term goal is to elucidate in vivo markers of neuropathology underlying the cognitive and motor decline observed in heavy drinking HIV-infected individuals or improvement with sustained abstinence from alcohol and their interaction with HIV disease status.

Federal Grant Title:	Announcement of a Limited Competition for the Continuation of the Cooperative Agreement on the Interaction of HIV Infection and Alcohol Abuse on Central Nervous System Morbidity (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AA-12-011
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.273
CFDA Descriptions:	Alcohol Research Programs
Current Application Deadline:	Apr 16, 2012
Original Application Deadline:	Apr 16, 2012
Posted Date:	January 18th, 2012
Creation Date:	Jan 18, 2012
Archive Date:	May 17, 2012
Total Program Funding:	$1,210,000
Maximum Federal Grant Award:	$810,000
Minimum Federal Grant Award:
Expected Number of Awards:	1
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Specialized Alcohol Research Centers (P50 Clinical trial Optional); • Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Stud...; • Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Stud...; • Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional); • NIAID, NIDDK, NIDA, and NIAAA Research Opportunities for New and "At-Risk" Investigators (...; • Mechanisms of Alcoholic Pancreatitis; • Alcohol Abuse and Hiv/Aids in Resource-Poor Societies; • Mechanisms of Alcohol-Induced Tissue Injury
More Grants from the National Institutes of Health: • NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices ...; • Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...; • Immune Tolerance Network (UM1 Clinical Trial Required); • Coordinating Center for National Resource Network for the Study of Human Auditory and Vest...; • National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Cl...